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Background/aim: In this study, it was aimed to evaluate the change in antimicrobial efficacy related to the presence of the organic load
of four different antiseptic solutions that are frequently used in hospitals.
Materials and methods: Solutions of hydrogen peroxide, povidone-iodine, chlorhexidine digluconate, and ethyl alcohol were prepared,
tested in terms of antimicrobial efficacy changes in the presence of organic substances, and evaluated according to EN 13727 and EN
13624 standards.
Results: Among the investigated solutions ethanol 70% solution showed the best results by providing a 5-log reduction on all test
organisms without affecting by the type and concentration of organic substances. Solutions of hydrogen peroxide 3%, povidone-iodine
7.5%, and chlorhexidine digluconate 0.2% performed lower antimicrobial efficacy depending on the concentration of organic load.
Conclusion: It is concluded that the antimicrobial efficacy of antiseptic solutions is significantly affected by the organic substances and
thus the proper use of antiseptics has become important to achieve successful disinfection and prevention of antibacterial resistance.
Key words: Antiseptic solutions, organic load in hospitals, antimicrobial efficacy, EN 13727, EN 13624

1. Introduction
Antiseptic solutions are commonly used in hospitals
and other healthcare settings for a variety of topical
applications that kill or inhibit the growth of diseasecausing bacteria. Such antiseptic solutions are biocidal
products containing one or more active ingredients and are
commercially produced for different purposes of use such
as hand rub, hand wash, surgical solutions, mouthwashes,
and also for brushes. They are expected to have properties
like broad-spectrum, fast-acting, nonirritating, nontoxic,
and insignificant absorption into the application site
[1,2,3]. They play an important role in the prevention of
nosocomial infections, which are important risk factors
for morbidity and mortality especially due to antibioticresistant organisms in the healthcare fields [1,4,5]. It has
been determined that 20%–40% of these infections are
transmitted through the hands of healthcare staff touching
the patient or by contamination from the environment
[6]. Staphylococcus aureus, Methicillin-resistant S. aureus
(MRSA), Enterococcus faecalis, E. faecium, Vancomycinresistant Enterococci (VRE), broad-spectrum β-lactamase
(ESBL)-producing
Enterobacteriaceae,
Escherichia
coli, Pseudomonas aeruginosa, Acinetobacter spp. are

the leading microorganisms associated with hospitalacquired infections [5,7,8]. Candida albicans, the most
important fungus in terms of nosocomial infections,
causes septicaemia, urinary tract infections, or surgical
site infections. Antiseptic solutions containing hydrogen
peroxide, chlorhexidine, triclosan, ethyl alcohol, and
povidone-iodine active substances are formulated as
ready-to-use or concentrated solutions for hand hygiene
and wound antisepsis in the hospitals. Most antiseptics do
not have a specific form of action against microorganisms
as much as antibiotics, but their microbial activities show
significant differences depending on many factors such
as the presence of organic matter, microbial load, and
synergistic effects between active substances, time, and
temperature. The effects of some active substances may be
reduced due to various effects, especially in the presence
of organic substances, and cannot show the expected
microbial reduction [2,9,10]. In addition to being used in
the hospital environment, antiseptic solutions are widely
used all over the world due to the Covid 19 pandemic. In
this direction, it has become more important to investigate
the factors affecting the effectiveness of antiseptic solutions.
The failure to achieve the desired success in the use of
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antiseptic solutions is due to the fact that they are not used
properly and under appropriate conditions. Therefore, in
this study, it was aimed to examine the effect of organic
load, which is a conditional factor, on the effectiveness of
four antiseptic solutions that are widely used in the hospital
environment. The change in antimicrobial effectiveness of
prepared solutions of hydrogen peroxide (HP), povidoneiodine (PVP-I), chlorhexidine digluconate (CHX), and
ethyl alcohol (EtOH), which are used as hand and wound
antiseptics in hospitals were investigated in the presence
of organic load at different concentrations by using phase
2 step 1 specific suspension assays and evaluated by EN
13727 [11] and EN 13624 [12] standards. There are some
limitations in the applications related to the phase 2 step
2 trials on human hands; the use of only nonpathogenic
E. coli K12 strains in artificial contamination or the
inability to standardize the microbial load in studies to
be constructed with natural contamination. Thus, phase 2
step 1 trials are preferred in microbial activity studies. In
our study, assessment of the effectiveness of each antiseptic
solution was accomplished by using four bacterial strains
and yeast. The test strains included methicillin-resistant
Staphylococcus aureus (MRSA), vancomycin-resistant
Enterococcus faecalis (VRE), Escherichia coli, Pseudomonas
aeruginosa, and Candida albicans.
2. Materials and methods
Antiseptic solutions
The following antiseptic solutions were prepared and
tested:
·
Hydrogen peroxide (HP) (3%) was prepared
from 30% hydrogen peroxide solution (CAS No.7722-84-1
0 Sigma-Aldrich) diluted with distilled water.
·
Povidone-iodine (PVP-I) (7.5%) was prepared
from poly(vinylpyrrolidone) (PVP)–iodine complex (CAS
No. 25655-41-8 Sigma-Aldrich) diluted with citric acidphosphate buffer solution (pH 5.0).
·
Chlorhexidine digluconate (CHX) (0.2%) was
prepared from a 20% stock solution (CAS No. 18472-51-0
Sigma-Aldrich) diluted with distilled water.
·
Ethyl alcohol (EtOH) (70%) was prepared from
96% ethyl alcohol (CAS No. 64-17-5, Merck Millipore)
diluted with distilled water.
Test organisms
The test organisms were methicillin-resistant
Staphylococcus aureus (ATCC 43300), vancomycinresistant Enterococcus faecalis (ATCC 51299), Pseudomonas
aeruginosa (ATCC 15442), Escherichia coli K12 (NCTC
10538), Candida albicans (ATCC 10231).
Interfering substances
Two different organic challenges were investigated;
bovine serum albumin (BSA, CAS No: 9048-46-8, Sigma
Aldrich): 0.1%, 0.3%, 0.5%, 1.0%, 1.5%, 3.0%, 5.0%,
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10.0%, and defibrinated sheep blood (DSB, Thermo Fisher
Scientific): 0.1%, 0.3%, 0.5%, 1.0%, 1.5%, 3.0%, 5.0%,
10.0%.
Neutralizers
Appropriate neutralizers (for EtOH: 3 g/L Lecithin,
30 g/L Saponin, 30 g/L Polysorbate 80; for HP: 10 g/L
Lecithin, 0.25 g/L Catalase, 50 g/L Polysorbate 80; for
PVP-I: 3 g/L Lecithin, 15 g/L Sodium Thiosulphate, 30 g/L
Polysorbate 80; for CHX 3 g/L Lecithin, 30 g/L Saponin,
1 g/L L-histidine, 30 g/L Polysorbate 80) were used to
inactivate the active substance residues at the end of the
contact period. Neutralizer compositions are shown in
Table 1. It was also tested whether neutralizers showed
toxicity on microorganisms.
2.1. Quantitative suspension test procedure
Bactericidal and yeasticidal activity tests were performed
according to EN 13727 and EN 13624 protocols,
respectively [4,5]. Reference organisms were prepared by
densitometer within the range of 1.5 × 108 to 5.0 × 108 CFU
mL−1 for bacteria and 1.5 x 107–5.0 x 107 CFU mL−1 for
yeast for 18–24 h.
Bovine serum albumin (BSA) and the defibrinated
sheep blood (DSB) were prepared at the above
concentrations just prior to testing. One mL of interfering
substances were transferred into sterile tubes and 1 mL
of each culture suspension were added and waited for 2
min. After the 2-minute equilibration, 8 mL of antiseptic
solutions (×1.25 of the final test concentration) were
added and waited for the 1 min of contact time. At the
end of contact time, aliquots of 1 mL were transferred to
appropriate neutralization solutions (Table 1). After 5 min
of neutralization time, 0.5 mL of test mixtures and serial
dilutions (10−1 and 10−2) were plated on appropriate agar
medium (TSA for bacteria, MEA for yeast) in duplicates.
After incubation for 48 h (37 °C for bacteria and 30 °C
for fungi) colonies were counted. In addition, interfering
substance and neutralization controls (test validations)
were applied as described in EN standards.
2.2. Calculation of reduction
The logarithmic reduction was calculated according to EN
standards using the following formula;
lgR = lgN0−lgNa
lg N0 = number of colonies at the beginning of contact
time
lg Na = number of colonies at the end of contact time
3. Results
The results showed that depending on the organic load
investigated, four different antiseptic solutions presented
different effectiveness. Antimicrobial activities of
antiseptic solutions were tested on 4 different bacteria and
1 yeast, including antibiotic-resistant strains, at different
concentrations of 2 different organic substances BSA and
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Table 1. Reduction factors obtained with HP-3% solution.
MRSA

VRE

E. coli

P. aeruginosa

C. albicans

BSA

4.02 ± 0.13

0.42 ± 0.04

5.10 ± 0.11

5.22 ± 0.10

0.22 ± 0.17

DSB

2.69 ± 0.22

2.35 ± 0.18

5.13 ± 0.13

5.08 ± 0.08

0.20 ± 0.12

BSA

3.38 ± 0.04

0.36 ± 0.12

5.10 ± 0.21

5.22 ± 0.02

0.21 ± 0.16

DSB

2.55 ± 0.11

2.25 ± 0.24

5.13 ± 0.15

5.08 ± 0.05

0.16 ± 0.10

BSA

3.17 ± 0.30

0.28 ± 0.25

4.61 ± 0.11

5.22 ± 0.03

0.15 ± 0.13

DSB

2.24 ± 0.12

2.12 ± 0.24

4.94 ± 0.24

5.08 ± 0.05

0.15 ± 0.15

BSA

2.86 ± 0.16

0.18 ± 0.26

3.34 ± 0.13

4.68 ± 0.20

0.14 ± 0.62

DSB

2.21 ± 0.08

2.03 ± 0.07

4.04 ± 0.16

5.08 ± 0.06

0.13 ± 0.45

BSA

1.69 ± 0.10

0.14 ± 0.11

3.12 ± 0.06

4.44 ± 0.07

0.15 ± 0.33

DSB

1.80 ± 0.20

1.82 ± 0.33

3.91 ± 0.22

4.71 ± 0.24

0.12 ± 0.30

BSA

1.44 ± 0.16

0.11 ± 0.35

2.80 ± 0.24

3.66 ± 0.14

0.11 ± 0.38

DSB

0.90 ± 0.25

1.25 ± 0.10

3.37 ± 0.18

3.95 ± 0.16

0.07 ± 0.30

BSA

1.34 ± 0.32

0.04 ± 0.20

2.64 ± 0.25

3.41 ± 0.22

0.10 ± 0.23

DSB

0.78 ± 0.22

1.12 ± 0.24

3.27 ± 0.30

3.52 ± 0.25

0.04 ± 0.26

BSA

1.24 ± 0.11

0.02 ± 0.24

2.39 ± 0.04

3.30 ± 0.07

0.07 ± 0.34

DSB

0.62 ± 0.30

0.85 ± 0.23

2.96 ± 0.18

3.20 ± 0.10

0.05 ± 0.25

Interfering Substance
0.1 g/L
0.3 g/L
0.5 g/L
1.0 g/L
1.5 g/L
3.0 g/L
5.0 g/L
10.0 g/L

DSB. One-min period specified in the EN standards was
applied as contact time. Bactericidal and yeasticidal efficacy
data obtained in the tests are below presented in separate
tables for each test solution (Table 1–4). According to EN
13624 and 13727 standards, bactericidal and yeasticidal
efficacy limits are 5 log and 4 log, respectively. When the
effectiveness of antiseptic solutions was compared under
standard test conditions, the efficacy of active ingredients
other than ethyl alcohol was reduced in the presence of
gradually increasing organic load.
HP 3% solution showed 5-log reduction only on P.
aeruginosa and E. coli. However, this effect gradually
decreased when the BSA concentration increased above
0.5% and the DSB concentration above 1%. A limit value
for MRSA, VRE, and C.albicans was not achieved in any
trial and almost no effect was observed especially in the
presence of high organic substances (Figure 1).
7.5% PVP-I solution provided the desired 5-log
and 4-log reduction in standards against gram negative
bacteria and C. albicans, respectively, similar to HP 3%
solution, but the efficacy did not reach the desired value
for MRSA and especially VRE (Figure 2).
CHX-0.2% solution, which provided a 5-log reduction
in P. aeruginosa and E. coli and a 4-log reduction in
C.albicans up to 0.5% BSA concentration, showed a lower
efficacy in the presence of DSB. In the presence of a high
organic load, an activity varying between 1.72 and 3.04
log was achieved against these organisms. While this
antiseptic provided a maximum reduction of around 3 log

in MRSA, the reduction in VRE was determined to be at
most 2 log (Figure 3).
In our efficacy trials, EtOH-70% was observed to be
the antiseptic solution that provided the logarithmic
reduction to meet the standards in all test organisms and
at each concentration value (Figure 4).
4. Discussion
When the results were evaluated, the highest efficacy
was found with the ethanol including EtOH-70%
solution. The factors determining the degree of
effectiveness in other active substances were both
the organic load and the type of microorganism. The
response of antiseptic solutions to organic substances
varies in relation to the chemical structures of their
active ingredients. The action mechanism of antiseptic
solutions plays a key role in varying effectiveness against
different microorganisms [13]. It has been observed that
especially antibiotic-resistant strains are more resistant
to antiseptic solutions. To determine the bactericidal
and fungicidal activities of antiseptic solutions, BSA and
DSB are used interfering substances to simulate organic
contamination in the wound surface or skin tissue,
according to EN methods. A test model was designed to
determine the response of different antiseptic solutions
in the presence of 2 different types of organic load and
their varying concentrations to make more accurate
predictions about the potential performance of an
antiseptic solution in clinical use.
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Table 2. Reduction factors obtained with PVP-7.5% solution.
MRSA

VRE

E. coli

P. aeruginosa

C. albicans

BSA

4.94 ± 0.22

1.52 ± 0.10

5.12 ± 0.05

5.09 ± 0.06

4.14 ± 0.12

DSB

4.12 ± 0.20

0.78 ± 0.32

5.03 ± 0.02

5.05 ± 0.04

4.04 ± 0.04

BSA

4.69 ± 0.14

1.37 ± 0.42

5.12 ± 0.07

5.09 ± 0.08

4.14 ± 0.07

DSB

3.91 ± 0.22

0.75 ± 0.24

5.03 ± 0.22

5.05 ± 0.03

4.04 ± 0.05

BSA

4.38 ± 0.15

1.11 ± 0.21

5.12 ± 0.06

5.09 ± 0.07

4.14 ± 0.10

DSB

3.84 ± 0.24

0.64 ± 0.26

5.03 ± 0.12

5.05 ± 0.02

4.04 ± 0.13

BSA

4.43 ± 0.26

0.95 ± 0.25

5.12 ± 0.04

5.09 ± 0.07

4.14 ± 0.12

DSB

3.69 ± 0.28

0.61 ± 0.36

5.03 ± 0.02

5.05 ± 0.12

4.04 ± 0.11

BSA

3.73 ± 0.32

0.79 ± 0.34

5.12 ± 0.07

5.09 ± 0.06

4.14 ± 0.05

DSB

3.24 ± 0.24

0.59 ± 0.27

5.03 ± 0.04

5.05 ± 0.05

4.04 ± 0.04

BSA

3.22 ± 0.18

0.73 ± 0.25

5.12 ± 0.05

5.09 ± 0.11

4.14 ± 0.07

DSB

2.68 ± 0.26

0.56 ± 0.28

5.03 ± 0.02

5.05 ± 0.06

4.04 ± 0.08

BSA

3.09 ± 0.12

0.70 ± 0.38

5.12 ± 0.11

5.09 ± 0.07

4.14 ± 0.06

DSB

2.53 ± 0.16

0.55 ± 0.42

5.03 ± 0.08

5.05 ± 0.06

4.04 ± 0.12

BSA

2.70 ± 0.20

0.65 ± 0.35

5.12 ± 0.12

5.09 ± 0.06

4.14 ± 0.10

DSB

2.50 ± 0.24

0.54 ± 0.22

5.03 ± 0.10

5.05 ± 0.07

4.04 ± 0.02

Interfering Substance
0.1 g/L
0.3 g/L
0.5 g/L
1.0 g/L
1.5 g/L
3.0 g/L
5.0 g/L
10.0 g/L

Table 3. Reduction factors obtained with CHX-0.2% solution.
MRSA

VRE

E. coli

P. aeruginosa

C. albicans

BSA

3.11 ± 0.36

2.12 ± 0.22

5.13 ± 0.06

5.03 ± 0.05

4.17 ± 0.10

DSB

2.89 ± 0.18

0.74 ± 0.31

4.18 ± 0.26

3.70 ± 0.36

3.63 ± 0.05

BSA

2.80 ± 0.26

1.72 ± 0.21

5.13 ± 0.04

5.03 ± 0.11

4.17 ± 0.07

DSB

2.60 ± 0.18

0.68 ± 0.24

4.05 ± 0.20

3.65 ± 0.12

3.48 ± 0.08

BSA

2.41 ± 0.32

1.43 ± 0.14

5.13 ± 0.05

5.03 ± 0.10

4.17 ± 0.19

DSB

2.24 ± 0.17

0.66 ± 0.35

3.99 ± 0.20

3.57 ± 0.27

3.44 ± 0.11

BSA

2.12 ± 0.29

1.24 ± 0.30

4.86 ± 0.27

4.55 ± 0.24

3.76 ± 0.25

DSB

1.90 ± 0.23

0.60 ± 0.34

3.75 ± 0.30

3.02 ± 0.17

2.42 ± 0.14

BSA

1.91 ± 0.27

1.08 ± 0.35

4.74 ± 0.17

4.44 ± 0.05

3.51 ± 0.13

DSB

1.71 ± 0.24

0.56 ± 0.22

2.84 ± 0.21

2.64 ± 0.18

2.37 ± 0.16

BSA

1.70 ± 0.21

0.95 ± 0.24

3.80 ± 0.15

3.56 ± 0.20

2.87 ± 0.25

DSB

1.52 ± 0.22

0.54 ± 0.24

2.54 ± 0.23

2.32 ± 0.38

2.21 ± 0.34

BSA

1.53 ± 0.20

0.83 ± 0.30

3.23 ± 0.15

3.21 ± 0.13

2.41 ± 0.25

DSB

1.37 ± 0.30

0.42 ± 0.16

2.44 ± 0.20

2.30 ± 0.10

2.01 ± 0.30

BSA

1.40 ± 0.25

0.72 ± 0.14

3.04 ± 0.12

2.88 ± 0.22

2.30 ± 0.16

DSB

1.30 ± 0.31

0.34 ± 0.38

2.34 ± 0.21

1.84 ± 0.24

1.72 ± 0.38

Interfering Substance
0.1 g/L
0.3 g/L
0.5 g/L
1.0 g/L
1.5 g/L
3.0 g/L
5.0 g/L
10.0 g/L

Obtained results showed that HP 3% solution provided
the desired 5-log reduction in the standard only at low
concentrations of organic substances in P. aeruginosa and
E. coli bacteria, and the efficiency decreased inversely
as the amount of organic substance increased. While a
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4-log reduction was achieved on MRSA in the presence
of 0.1 g/L BSA, this effect decreased to around 1 log
with increasing concentrations of BSA. In the presence
of DSB, the effectiveness was observed to be less. It was
determined that HP did not show any antimicrobial
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Table 4. Reduction factors obtained with EtOH-70% solution.
MRSA

VRE

E. coli

P. aeruginosa

C. albicans

BSA

5.06 ± 0.06

5.18 ± 0.07

5.13 ± 0.13

5.17 ± 0.15

4.22 ± 0.07

DSB

5.17 ± 0.04

5.21 ± 0.12

5.04 ± 0.16

5.14 ± 0.11

4.06 ± 0.15

BSA

5.06 ± 0.10

5.18 ± 0.05

5.13 ± 0.04

5.17 ± 0.12

4.22 ± 0.11

DSB

5.17 ± 0.13

5.21 ± 0.16

5.04 ± 0.06

5.14 ± 0.10

4.06 ± 0.07

BSA

5.06 ± 0.07

5.18 ± 0.07

5.13 ± 0.14

5.17 ± 0.12

4.22 ± 0.05

DSB

5.17 ± 0.11

5.21 ± 0.04

5.04 ± 0.05

5.14 ± 0.06

4.06 ± 0.10

BSA

5.06 ± 0.06

5.18 ± 0.11

5.13 ± 0.14

5.17 ± 0.04

4.22 ± 0.05

DSB

5.17 ± 0.12

5.21 ± 0.11

5.04 ± 0.16

5.14 ± 0.04

4.06 ± 0.07

BSA

5.06 ± 0.10

5.18 ± 0.12

5.13 ± 0.07

5.17 ± 0.07

4.22 ± 0.08

DSB

5.17 ± 0.04

5.21 ± 0.14

5.04 ± 0.06

5.14 ± 0.05

4.06 ± 0.05

BSA

5.06 ± 0.05

5.18 ± 0.10

5.13 ± 0.14

5.17 ± 0.16

4.22 ± 0.10

DSB

5.17 ± 0.06

5.21 ± 0.14

5.04 ± 0.11

5.14 ± 0.12

4.06 ± 0.06

BSA

5.06 ± 0.10

5.18 ± 0.05

5.13 ± 0.00

5.17 ± 0.02

4.22 ± 0.11

DSB

5.17 ± 0.06

5.21 ± 0.06

5.04 ± 0.07

5.14 ± 0.07

4.06 ± 0.12

BSA

5.06 ± 0.07

5.18 ± 0.12

5.13 ± 0.10

5.17 ± 0.06

4.22 ± 0.14

DSB

5.17 ± 0.11

5.21 ± 0.16

5.04 ± 0.05

5.14 ± 0.04

4.06 ± 0.05

Interfering Substance
0.1 g/L
0.3 g/L
0.5 g/L
1.0 g/L
1.5 g/L
3.0 g/L
5.0 g/L
10.0 g/L

Figure 1: Reduction factors obtained with HP-3% solution.
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Figure 1. Reduction factors obtained with HP-3% solution.

activity against VRE and C. albicans, especially in the
presence of BSA (Figure 1), which is in accordance with
the results of the study in which the antimicrobial activity
against E. faecium and C. albicans was investigated [9]. HP
is a biocidal active agent with a wide range of uses, from
antisepsis to disinfection and equipment sterilization, due
to its environmental friendliness and rapid conversion

to harmless products such as oxygen and water. HP
degrades microbial structure by producing hydroxyl free
radicals (-OH) that attack key cell components, including
proteins, enzymes, lipids, and DNA. However, its biggest
disadvantage is that it is rapidly reduced in the presence of
organic substances and decomposed by radical scavenger
enzymes such as catalase and peroxidase, thus it does not
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Figure 2: Reduction factors obtained with PVP-7.5% solution.
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Figure 2. Reduction factors obtained with PVP-7.5% solution.

Figure 3: Reduction factors obtained with CHX-0.2% solution.
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Figure 3. Reduction factors obtained with CHX-0.2% solution.

show any effect at low concentrations and in short periods
against microorganisms possess these enzymes.
Aqueous or alcoholic (tincture) solutions of iodine
have been used as antiseptics for over 150 years. By the
development of iodine carrier or release iodophors, some
disadvantages such as irritability and instability of iodine
have been overcome [14,15]. PVP-I, in which elemental
iodine forms a complex with the polyvinylpyrrolidone
carrier, has a rapid effect against bacteria, yeasts, viruses,
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and protozoa, as the effect is very low against molds and
spores [2]. PVP-I is frequently used in the medical field as
a disinfectant or topical antiseptic in the form of solution,
powder, or lotion formulations. High antimicrobial activity
against bacteria and yeasts and relatively lower efficacy
against A. brasiliensis of PVP-I solution have been reported
[3]. Although its mechanism of action has not been fully
elucidated, it is thought to cause deterioration of the function
and structure of the cell by reacting with the functional
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Figure 4: Reduction factors obtained with EtOH-70% solution.
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Figure 4. Reduction factors obtained with EtOH-70% solution.

groups of amino acids, nucleotides, and fatty acids in the
cell membrane, cell wall, and cytoplasm [1,14]. Enveloped
viruses are more sensitive to iodophors than other viruses.
Similar to bacteria, iodine attacks the surface proteins of
enveloped viruses, as well as destabilizes the membrane
by reacting with the carbon bonds in the unsaturated fatty
acids of the membrane [15]. Our results showed that 7.5%
PVP-I solution reduced 5 logs of E. coli and P. aeruginosa
and 4 logs of C. albicans under the investigated conditions
related to organic substances. While a 4-log reduction was
achieved in low BSA and blood concentrations against
MRSA, it was determined that this effect regressed to
around 2.5 log as the concentration increased. VRE was
noted as the most resistant organism to PVP-I solution.
While only 1.52-log reduction was obtained at the lowest
BSA concentration, this efficacy decreased inversely with
the BSA concentration. When DFB is used as the interfering
substance, even 1-log reduction in the organism could not
be achieved (Figure 2).
In the case of CHX solution, the results showed that
it was the antiseptic most significantly affected by organic
substance type and its concentration. When DFB was
used as the organic substance, a relatively lower effect
was observed compared to BSA. Antimicrobial activity
decreased significantly with increasing concentration.
Similar to the results with other antiseptic solutions, the
most resistant strain to CHX was found to be VRE (Figure
3). CHX is a broad-spectrum biocide used both as a
hand sanitizer and an oral antiseptic, formed by chlorine
binding to two guanidine. In addition to its advantages
such as being nonirritant and long-lasting effect on the

skin, its effectiveness varies highly depending on pH and
the concentration of organic load. CHX salts are positively
charged and therefore tightly bound to the negatively
charged bacterial cell wall and membrane. This binding
results in the death of the cell as it causes deterioration
in the bacterial wall and membrane structure. Some
researchers have also found that high concentrations of
CHX inhibit the ATPase enzyme [14,16].
Alcohols,
especially
ethanol
(at
60%–80%
concentration), are active ingredients that are frequently
used in the medical field as both antiseptic and disinfectant.
The antimicrobial mechanism of ethanol is to disrupt
membrane integrity and denature proteins. The hydrogen
bonding of the hydroxyl group (-OH) in alcohols to
proteins results in the loss of structure and function
of microbial proteins and enzymes. Although alcohols
have a broad-spectrum effect, they are not sporicidal but
have sporostatic activity [14,17]. According to the results
obtained by ethanol 70% solution, it provided a 5-log
reduction on all test organisms. It has been determined
that ethanol 70% solution is not affected by the type
of organic substances and its concentration used, and
the efficiency continues without decreasing even at the
highest organic substance concentration (Figure 4). In the
experiments, globular proteins albumin and haemoglobin
were used as interfering substances. The organic solvent
ethanol denatures proteins at high concentrations because
of hydrophobic interactions. Therefore, it is thought that
ethanol may not be affected by interfering agents [18].
In our study, changes in the microbiological activities
of the most commonly used antiseptic solutions in
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the hospitals were observed against different organic
interfering substances and their different concentrations. It
has been determined that among the active substances used
as antiseptics, other than ethyl alcohol, there are changes
in their effectiveness at different levels depending on the
concentration of organic load, and there is a decrease in
their antimicrobial activities inversely proportional to the
increasing concentration organic substances. It has been
observed that MRSA and VRE, which play an important
role in nosocomial infections and cannot be treated easily
due to their antibiotic resistance, are more resistant to
antiseptics than other tested microorganism strains, and
that other active substances other than ethanol, especially
against VRE, cannot provide successful efficacy even at low
organic load concentrations. On the other hand, Pitten et al.
[9] determined that the microbial efficiency of antiseptics
containing oxidizing agents is higher when there is no
organic load. In addition to organic load, it is known that the
contact time is an important variable on the effectiveness,
the effectiveness increases in direct proportion to the
contact time, but this time is limited to 5 min in the EN
13727 standard for antiseptic products used in the medical
field on the human body [3].
Improper use of antiseptics or disinfectants causes
microorganisms to not be eliminated, activates resistance
genes, increases bacterial tolerance, and leads to
phenotypic adaptations. In addition, resistance genes can

be horizontally transferred and cause other organisms to
become resistant. The growth rate of disinfectant-resistant
bacteria is very high, which reduces the effectiveness of
disinfectants. Multidrug-resistant bacteria ultimately pose a
serious threat to human and environmental health [19,20].
5. Conclusion
The use of antiseptic and disinfectant solutions in healthcare
settings, ensuring the hygiene of patients and healthcare
staff, play a key role in the prevention of nosocomial
infections and bacterial resistance. To get optimum
efficiency from antiseptic and disinfectant solutions,
attention should be paid to the active ingredients, usage
area, and contact time. The effectiveness of many antiseptic
products decreases depending on the organic load in the
environment. Improper use of antiseptics resulted in a
decrease in their efficacy and increased bacterial tolerance.
Organic load-related changes in the activity of antiseptics
could be controlled by deciding proper antiseptics and ethyl
alcohol-included antiseptics could overcome high organic
load risk related to unwanted bacterial resistance.
Acknowledgment and/or disclaimers
The authors declared no financial support for this research.
Conflict of interest
The authors declare that they have no conflicts of interest.

References
1.

Hoang TPN, Ghori MUU, Conway BR. Topical antiseptic
formulations for skin and soft tissue infections. Pharmaceutics
2021; 13(4): 558. doi: 10.3390/pharmaceutics13040558

2.

3.

4.

5.

832

6.

Mcdonnell G, Russell D. Antiseptics and disinfectants: activity,
action, and resistance. Clinical Microbiology Reviews 1999; 12:
147-179. doi: 10.1128/CMR.12.1.147

Carling PC, Bartley JM. Evaluating hygienic cleaning in health
care settings: what you do not know can harm your patients.
American Journal of Infection Control 2010; 38: 41-50. doi:
10.1016/j.ajic.2010.03.004

7.

Şahiner A, Halat E, Algın Yapar E. Comparison of bactericidal
and fungicidal efficacy of commonly used antiseptic
formulations according to European standards EN 13727 and
EN 13624. Turkish Journal of Medical Sciences 2019; 49: 15641567. doi: 10.3906/sag-1906-53

Kampf G, Kramer A. Epidemiologic background of hand
hygiene and evaluation of the most important agents for scrubs
and rubs. Clinical Microbiology Review 2004;17(4): 863-893.
doi: 10.1128/CMR.17.4.863-893.2004

8.

Radischat N, Augustin M, Herberger K, Wille A, Goroncy‐
Bermes P. Influence of human wound exudate on the
bactericidal efficacy of antiseptic agents in quantitative
suspension tests on the basis of European Standards (DIN EN
13727). International wound journal 2020; 17(3): 781-789. doi:
10.1111/iwj.13336

Kim JM, Park ES, Jeong JS, Kim KM, Kim JM et al. Multicenter
surveillance study for nosocomial infections in major hospitals
in Korea. Nosocomial infection surveillance committee of the
Korean Society for Nosocomial Infection Control. American
Journal of Infection Control 2000; 28: 454–458. doi: 10.1067/
mic.2000.107592

9.

Pitten FA, Werner HP, Kramer A. A standardized test to assess
the impact of different organic challenges on the antimicrobial
activity of antiseptics. Journal of Hospital Infection 2003;
55(2): 108-115. doi: 10.1016/s0195-6701(03)00260-3

10.

Nicolae Dopcea G, Diguta CF, Matei F, Dopcea I, Nanu AE.
Resistance and cross-resistance in Staphylococcus spp. strains
following prolonged exposure to different antiseptics. Journal
of Global Antimicrobial Resistance 2020; 21: 399–404. doi:
10.1016/j.jgar.2019.10.021

Chowdhury D, Rahman A, Hu H, Jensen SO, Deva AK et
al. Effect of disinfectant formulation and organic soil on the
efficacy of oxidizing disinfectants against biofilms. Journal
of Hospital Infection 2019; 103(1): 33-41. doi: 10.1016/j.
jhin.2018.10.019

ŞAHİNER et al. / Turk J Med Sci
11.

EN 13727:2015. Chemical disinfectants. Quantitative
suspension test for the evaluation of bactericidal activity
for instruments used in the medical area. Test method and
requirements (phase 2/step 1).

16.

Cheung HY, Wong MMK, Cheung SH, Liang LY, Lam YW
et al. Differential actions of chlorhexidine on the cell wall of
Bacillus subtilis and Escherichia coli. Public Library of Science
One 2012; 7(5), e36659. doi: 10.1371/journal.pone.0036659

12.

EN 13624:2013. Chemical disinfectants and antiseptics Quantitative suspension test for the evaluation of fungicidal
activity of chemical disinfectants for instruments used in the
medical area - Test method and requirements (phase 2, step 1).

17.

McDonnell G. General mechanism of action. In: McDonnel
GE, eds. Antisepsis, Disinfection, and Sterilization. 2nd ed.
Washington DC: American Society for Microbiology Press
2017. pp. 255-269.

13.

Chowdhury D, Rahman A, Hu H, Jensen SO, Deva AK et
al. Effect of disinfectant formulation and organic soil on the
efficacy of oxidizing disinfectants against biofilms. Journal
of Hospital Infection 2019; 103(1): 33-41. doi: 10.1016/j.
jhin.2018.10.019

18.

Yoshikawa H, Hirano A, Arakawa T, Shiraki K. Mechanistic
insights into protein precipitation by alcohol. International
journal of biological macromolecules 2012; 50(3), 865-871.
doi: 10.1016/j.ijbiomac.2011.11.005

19.

Kim M, Weigand MR, Oh S, Hatt JK, Krishnan R et al. Widely
used benzalkonium chloride disinfectants can promote
antibiotic resistance. Applied Environmental Microbiology
2018; 84: 7–19. doi: 10.1128/AEM.01201-18

20.

Tong C, Hu H, Chen G, Li Z, Li A et al. Disinfectant resistance
in bacteria: mechanisms, spread, and resolution strategies.
Environmental Research 2021; 110897. doi: 10.1016/j.
envres.2021.110897

14.

Yoo JH. Review of disinfection and sterilization–back to
the basics. Infection& Chemotherapy 2018; 50(2): 101. doi:
10.3947/ic.2018.50.2.101

15.

McDonnell GE. Antisepsis, Disinfection, and Sterilization:
Types, Action, and Resistance; American Society for
Microbiology Press: Washington, DC, USA, 2007.

833

